Pluribus Labs’s Deluxe DLX Stock Holding History

Pluribus Labs’s Portfolio DLX Stock Details DLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,317	Closed	-$203K	–	104
2021 Q4	$203K	Buy	+6,317	New	+$223K	0.21%	213

Other funds holding DLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pluribus Labs's DLX Position: Q1 2022 in Review

Pluribus Labs sold out of Deluxe (DLX) in Q1 2022, closing a stake of 6,317 shares — an estimated $203K sold.

Pluribus Labs first reported a position in DLX in Q4 2021 and held it in 1 quarter. The position peaked at $203K in Q4 2021. 196 funds tracked by Wall St. Rank hold DLX as of Q1 2022.

Pluribus Labs reported no remaining Deluxe position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 6,317 Deluxe shares in Q1 2022, an estimated $203K.
Pluribus Labs first reported a position in Deluxe in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Deluxe position peaked at $203K in Q4 2021.
196 funds tracked by Wall St. Rank held Deluxe as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.